Can a strong support system help people with dual diagnosis? new study investigates
NCT ID NCT07443033
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at 125 hospitalized adults who have both a mental disorder and a substance use problem (dual diagnosis). Researchers want to see if things like social support and coping skills are linked to better treatment adherence and daily functioning. The goal is to find protective factors that could guide more personalized care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify key psychosocial factors that improve treatment adherence and outcomes for people with dual diagnosis, leading to better care plans.
- What could go wrong
- This is an early observational study with only 125 participants at one hospital, so results may not apply to everyone. It looks at associations, not causes, so it cannot prove what works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 125 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Mar 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult inpatients hospitalized in a general hospital with a clinical diagnosis of dual diagnosis.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults (≥18 years). * Hospitalized patients with a clinical diagnosis of dual diagnosis. * Ability to provide informed consent. Exclusion Criteria: * Severe cognitive impairment or acute clinical condition preventing assessment. * Refusal or inability to provide informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dual diagnosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hospital Virgen del Puerto
Plasencia, Caceres, 10600, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Relationship-Focused therapy curb addiction cravings?
- Can a Text-Message program help trauma survivors avoid PTSD and depression?
- Can flexible mental health care keep people out of the hospital?
- Can a 6,000-Person study unlock personalized depression care for asians?
- Brain zaps synced to brain waves may curb meth cravings
- A window into young hearts: new biomarkers may spot antipsychotic side effects early